Literature DB >> 25403611

Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Alfonso Eirin1, Amir Lerman1, Lilach O Lerman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25403611      PMCID： PMC4289015          DOI： 10.1161/HYPERTENSIONAHA.114.04598

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  78 in total

Review 1.  Regulation of cell death: the calcium-apoptosis link.

Authors:  Sten Orrenius; Boris Zhivotovsky; Pierluigi Nicotera
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

2.  Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization.

Authors:  Kazuhiro Niimi; Takahiro Yasui; Masahito Hirose; Shuzo Hamamoto; Yasunori Itoh; Atsushi Okada; Yasue Kubota; Yoshiyuki Kojima; Keiichi Tozawa; Shoichi Sasaki; Yutaro Hayashi; Kenjiro Kohri
Journal:  Free Radic Biol Med       Date:  2012-01-18       Impact factor: 7.376

3.  Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz; Alfiya Bikineyeva; Lula Hilenski; Bernard Lassègue; Kathy K Griendling; David G Harrison; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

4.  Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.

Authors:  Alejandro R Chade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

5.  A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis.

Authors:  Alfonso Eirin; Zilun Li; Xin Zhang; James D Krier; John R Woollard; Xiang-Yang Zhu; Hui Tang; Sandra M Herrmann; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

6.  Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats.

Authors:  W Z Ying; P W Sanders
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

Review 7.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

8.  The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

Authors:  Alexander V Birk; Shaoyi Liu; Yi Soong; William Mills; Pradeep Singh; J David Warren; Surya V Seshan; Joel D Pardee; Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 10.121

9.  Angiotensin II induces apoptosis in renal proximal tubular cells.

Authors:  Madhu Bhaskaran; Krishna Reddy; Neetu Radhakrishanan; Nicholas Franki; Guohua Ding; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2003-01-14

10.  From bioblasts to mitochondria: ever expanding roles of mitochondria in cell physiology.

Authors:  Brian O'Rourke
Journal:  Front Physiol       Date:  2010-06-15       Impact factor: 4.566
View more
  31 in total

Review 1.  Novel therapeutic strategies for renovascular disease.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

2.  Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension.

Authors:  Anastasia Familtseva; Pankaj Chaturvedi; Anuradha Kalani; Nevena Jeremic; Naira Metreveli; George H Kunkel; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

3.  Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients.

Authors:  Alfonso Eirin; Ahmed Saad; Hui Tang; Sandra M Herrmann; John R Woollard; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

4.  A hypertension-associated mitochondrial DNA mutation alters the tertiary interaction and function of tRNALeu(UUR).

Authors:  Mi Zhou; Meng Wang; Ling Xue; Zhi Lin; Qiufen He; Wenwen Shi; Yaru Chen; Xiaofen Jin; Haiying Li; Pingping Jiang; Min-Xin Guan
Journal:  J Biol Chem       Date:  2017-07-05       Impact factor: 5.157

5.  Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress.

Authors:  Anna E Dikalova; Arvind Pandey; Liang Xiao; Liaisan Arslanbaeva; Tatiana Sidorova; Marcos G Lopez; Frederic T Billings; Eric Verdin; Johan Auwerx; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2019-12-19       Impact factor: 17.367

6.  A hypertension-associated mitochondrial DNA mutation introduces an m1G37 modification into tRNAMet, altering its structure and function.

Authors:  Mi Zhou; Ling Xue; Yaru Chen; Haiying Li; Qiufen He; Bibin Wang; Feilong Meng; Meng Wang; Min-Xin Guan
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

7.  Crosstalk Between Mitochondrial Hyperacetylation and Oxidative Stress in Vascular Dysfunction and Hypertension.

Authors:  Sergey I Dikalov; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2019-02-28       Impact factor: 8.401

Review 8.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.

Authors:  Teresa Pasqua; Sumana Mahata; Gautam K Bandyopadhyay; Angshuman Biswas; Guy A Perkins; Amiya P Sinha-Hikim; David S Goldstein; Lee E Eiden; Sushil K Mahata
Journal:  Cell Tissue Res       Date:  2015-11-16       Impact factor: 5.249

10.  Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension.

Authors:  Hana A Itani; Anna E Dikalova; William G McMaster; Rafal R Nazarewicz; Alfiya T Bikineyeva; David G Harrison; Sergey I Dikalov
Journal:  Hypertension       Date:  2016-04-11       Impact factor: 10.190
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.